Click on the subcategory below to find drug monographs for that particular area.
Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
The risks of metastasis and death associated with cutaneous squamous cell carcinoma are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond fat, poor differentiation, and location.
Men's middle-aged fitness level may protect against cancer.
Concurrent use of two immune checkpoint antibodies -- ipilimumab and nivolumab -- may be effective for the treatment of advanced melanoma.
Genetech announced results from CLL11, a Phase 3 study of obinutuzumab (GA101), comparing the combination of either obinutuzumab or Rituxan and chlorambucil to chlorambucil alone in chronic lymphocytic leukemia (CLL).
Older individuals with nonmelanoma skin cancer seem to have a significantly reduced risk of developing Alzheimer's disease.